(-)-demecolcine increases expression ISO RGD:732028 6480464 Demecolcine results in increased expression of NR4A2 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:732028 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A2 mRNA CTD PMID:22079256 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of NR4A2 protein CTD PMID:17337753 1,2-dichloroethane decreases expression ISO RGD:736400 6480464 ethylene dichloride results in decreased expression of NR4A2 mRNA CTD PMID:28960355 1,2-dimethylhydrazine increases expression ISO RGD:736400 6480464 1, 2-Dimethylhydrazine results in increased expression of NR4A2 mRNA CTD PMID:22206623 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine multiple interactions ISO RGD:736400 6480464 1 more ... CTD PMID:25406165 17beta-estradiol increases expression ISO RGD:732028 6480464 Estradiol results in increased expression of NR4A2 mRNA CTD PMID:19153601 17beta-estradiol increases expression EXP 6480464 Estradiol results in increased expression of NR4A2 mRNA CTD PMID:32145629 17beta-estradiol decreases expression ISO RGD:732028 6480464 Estradiol results in decreased expression of NR4A2 mRNA CTD PMID:21185374 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO RGD:736400 6480464 [2 more ... CTD PMID:25510870 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO RGD:736400 6480464 [2 more ... CTD PMID:25510870 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:736400 6480464 Tetrachlorodibenzodioxin affects the expression of NR4A2 mRNA CTD PMID:21570461 , PMID:24058054 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR4A2 mRNA CTD PMID:34747641 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of NR4A2 mRNA CTD PMID:32109520 , PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:732028 6480464 Tetrachlorodibenzodioxin results in decreased expression of NR4A2 mRNA CTD PMID:29704546 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:732028 6480464 [Tetrachlorodibenzodioxin co-treated with 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide] results in increased expression of NR4A2 mRNA CTD PMID:29704546 2-hydroxypropanoic acid increases expression ISO RGD:732028 6480464 Lactic Acid results in increased expression of NR4A2 mRNA CTD PMID:30851411 3,4-methylenedioxymethamphetamine decreases expression ISO RGD:736400 6480464 N-Methyl-3, 4-methylenedioxyamphetamine results in decreased expression of NR4A2 mRNA CTD PMID:20188158 3,7-dihydropurine-6-thione increases expression EXP 6480464 Mercaptopurine results in increased expression of NR4A2 mRNA CTD PMID:27435855 3,7-dihydropurine-6-thione multiple interactions EXP 6480464 [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 mRNA more ... CTD PMID:27435855 4,4'-diaminodiphenylmethane increases expression ISO RGD:736400 6480464 4, 4'-diaminodiphenylmethane results in increased expression of NR4A2 mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases methylation ISO RGD:736400 6480464 bis(4-hydroxyphenyl)sulfone results in increased methylation of NR4A2 exon CTD PMID:33297965 4,4'-sulfonyldiphenol affects methylation ISO RGD:736400 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of NR4A2 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:732028 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of NR4A2 mRNA CTD PMID:33885253 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of NR4A2 mRNA CTD PMID:22504374 , PMID:30047161 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of NR4A2 mRNA CTD PMID:25825206 8-Br-cAMP increases expression ISO RGD:732028 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of NR4A2 mRNA CTD PMID:22079614 acetaldehyde increases expression ISO RGD:732028 6480464 Acetaldehyde results in increased expression of NR4A2 mRNA CTD PMID:23416264 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of NR4A2 mRNA CTD PMID:22197712 acrylamide decreases expression ISO RGD:732028 6480464 Acrylamide results in decreased expression of NR4A2 mRNA CTD PMID:32763439 acrylamide affects expression EXP 6480464 Acrylamide affects the expression of NR4A2 mRNA CTD PMID:28959563 afimoxifene multiple interactions ISO RGD:732028 6480464 GPER1 protein affects the reaction [afimoxifene results in increased expression of NR4A2 mRNA] CTD PMID:19153601 afimoxifene increases expression ISO RGD:732028 6480464 afimoxifene results in increased expression of NR4A2 mRNA CTD PMID:19153601 aflatoxin B1 decreases expression ISO RGD:736400 6480464 Aflatoxin B1 results in decreased expression of NR4A2 mRNA CTD PMID:19770486 aflatoxin B1 affects expression ISO RGD:732028 6480464 Aflatoxin B1 affects the expression of NR4A2 protein CTD PMID:20106945 all-trans-retinoic acid multiple interactions ISO RGD:732028 6480464 [Tretinoin co-treated with SHH protein co-treated with FGF8 protein] results in increased expression of NR4A2 mRNA CTD PMID:17085092 all-trans-retinoic acid decreases expression ISO RGD:732028 6480464 Tretinoin results in decreased expression of NR4A2 mRNA CTD PMID:34742744 all-trans-retinoic acid increases expression ISO RGD:732028 6480464 Tretinoin results in increased expression of NR4A2 mRNA CTD PMID:33167477 amiodarone increases expression ISO RGD:732028 6480464 Amiodarone results in increased expression of NR4A2 mRNA CTD PMID:19774075 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of NR4A2 mRNA CTD PMID:16483693 amodiaquine multiple interactions ISO RGD:732028 6480464 Amodiaquine binds to and results in increased activity of NR4A2 protein CTD PMID:31175960 antimycin A increases expression ISO RGD:732028 6480464 Antimycin A results in increased expression of NR4A2 mRNA CTD PMID:33512557 arachidonic acid decreases expression ISO RGD:732028 6480464 Arachidonic Acid results in decreased expression of NR4A2 mRNA CTD PMID:16704987 aristolochic acid A increases expression ISO RGD:732028 6480464 aristolochic acid I results in increased expression of NR4A2 mRNA CTD PMID:33212167 arsane decreases expression ISO RGD:732028 6480464 Arsenic results in decreased expression of NR4A2 mRNA CTD PMID:16835338 arsane decreases expression ISO RGD:736400 6480464 Arsenic results in decreased expression of NR4A2 mRNA CTD PMID:19654921 arsenic atom decreases expression ISO RGD:732028 6480464 Arsenic results in decreased expression of NR4A2 mRNA CTD PMID:16835338 arsenic atom decreases expression ISO RGD:736400 6480464 Arsenic results in decreased expression of NR4A2 mRNA CTD PMID:19654921 arsenous acid decreases expression ISO RGD:732028 6480464 Arsenic Trioxide results in decreased expression of NR4A2 mRNA CTD PMID:26705709 atrazine decreases expression EXP 6480464 Atrazine results in decreased expression of NR4A2 mRNA, Atrazine results in decreased expression of NR4A2 protein CTD PMID:24552878 more ... atrazine increases expression EXP 6480464 Atrazine results in increased expression of NR4A2 mRNA CTD PMID:36841081 benzalkonium chloride increases expression ISO RGD:732028 6480464 Benzalkonium Compounds results in increased expression of NR4A2 mRNA CTD PMID:25377654 benzene increases expression ISO RGD:732028 6480464 Benzene results in increased expression of NR4A2 mRNA CTD PMID:19162166 benzo[a]pyrene increases expression ISO RGD:736400 6480464 Benzo(a)pyrene results in increased expression of NR4A2 mRNA CTD PMID:21569818 benzo[a]pyrene diol epoxide I decreases expression ISO RGD:732028 6480464 7 more ... CTD PMID:20018196 benzo[a]pyrene diol epoxide I increases expression ISO RGD:732028 6480464 7 more ... CTD PMID:20382639 bifenthrin decreases expression EXP 6480464 bifenthrin results in decreased expression of NR4A2 mRNA, bifenthrin results in decreased expression of NR4A2 protein CTD PMID:30978409 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of NR4A2 mRNA CTD PMID:25181051 bisphenol A increases methylation ISO RGD:732028 6480464 bisphenol A results in increased methylation of NR4A2 gene CTD PMID:31601247 bisphenol A decreases expression ISO RGD:736400 6480464 bisphenol A results in decreased expression of NR4A2 mRNA CTD PMID:33221593 bisphenol A increases expression ISO RGD:736400 6480464 bisphenol A results in increased expression of NR4A2 mRNA CTD PMID:30951980 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of NR4A2 mRNA CTD PMID:30816183 bisphenol A affects methylation ISO RGD:736400 6480464 bisphenol A affects the methylation of NR4A2 promoter CTD PMID:27334623 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of NR4A2 gene CTD PMID:28505145 bisphenol F increases expression ISO RGD:736400 6480464 bisphenol F results in increased expression of NR4A2 mRNA CTD PMID:30951980 bisphenol F decreases expression ISO RGD:736400 6480464 bisphenol F results in decreased expression of NR4A2 mRNA CTD PMID:36706583 buta-1,3-diene decreases expression ISO RGD:736400 6480464 1, 3-butadiene results in decreased expression of NR4A2 mRNA CTD PMID:29038090 butanal increases expression ISO RGD:732028 6480464 butyraldehyde results in increased expression of NR4A2 mRNA CTD PMID:26079696 C.I. Natural Red 20 multiple interactions ISO RGD:736400 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A2 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA] CTD PMID:25451590 cadmium atom increases expression ISO RGD:732028 6480464 Cadmium results in increased expression of NR4A2 mRNA CTD PMID:21694771 cadmium dichloride increases expression ISO RGD:732028 6480464 Cadmium Chloride results in increased expression of NR4A2 mRNA CTD PMID:26472689 Calcimycin multiple interactions ISO RGD:736400 6480464 shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA] CTD PMID:25451590 Calcimycin increases expression ISO RGD:736400 6480464 Calcimycin results in increased expression of NR4A2 mRNA CTD PMID:25451590 capecitabine decreases expression ISO RGD:732028 6480464 Capecitabine results in decreased expression of NR4A2 mRNA CTD PMID:36183961 carbon nanotube decreases expression ISO RGD:736400 6480464 Nanotubes more ... CTD PMID:25554681 carmustine affects expression EXP 6480464 Carmustine affects the expression of NR4A2 mRNA CTD PMID:19174181 Carnosol increases expression ISO RGD:736400 6480464 carnosol results in increased expression of NR4A2 protein CTD PMID:17047462 CGP 52608 multiple interactions ISO RGD:732028 6480464 CGP 52608 promotes the reaction [RORA protein binds to NR4A2 gene] CTD PMID:28238834 chloroquine multiple interactions ISO RGD:732028 6480464 Chloroquine binds to and results in increased activity of NR4A2 protein CTD PMID:31175960 chlorpyrifos decreases expression ISO RGD:736400 6480464 Chlorpyrifos results in decreased expression of NR4A2 mRNA CTD PMID:29156651 choline multiple interactions ISO RGD:736400 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NR4A2 gene CTD PMID:20938992 clozapine increases expression ISO RGD:736400 6480464 Clozapine results in increased expression of NR4A2 mRNA CTD PMID:17266109 cobalt dichloride increases expression ISO RGD:732028 6480464 cobaltous chloride results in increased expression of NR4A2 mRNA CTD PMID:19376846 cocaine decreases expression ISO RGD:732028 6480464 Cocaine results in decreased expression of NR4A2 protein CTD PMID:15094491 colforsin daropate hydrochloride increases expression ISO RGD:732028 6480464 Colforsin results in increased expression of NR4A2 mRNA, Colforsin results in increased expression of NR4A2 protein CTD PMID:19732956 , PMID:26023867 colforsin daropate hydrochloride multiple interactions ISO RGD:732028 6480464 666-15 compound inhibits the reaction [Colforsin results in increased expression of NR4A2 mRNA], NR4A2 protein inhibits the reaction [Colforsin results in increased expression of CYP19A1 mRNA] CTD PMID:19822197 , PMID:26023867 copper(II) sulfate increases expression ISO RGD:732028 6480464 Copper Sulfate results in increased expression of NR4A2 mRNA CTD PMID:19549813 corn oil increases expression EXP 6480464 Corn Oil results in increased expression of NR4A2 mRNA CTD PMID:22760963 coumestrol multiple interactions ISO RGD:732028 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA CTD PMID:19167446 crocidolite asbestos affects expression ISO RGD:732028 6480464 Asbestos, Crocidolite affects the expression of NR4A2 mRNA CTD PMID:25757056 crocidolite asbestos increases expression ISO RGD:732028 6480464 Asbestos, Crocidolite results in increased expression of NR4A2 mRNA CTD PMID:18687144 , PMID:24160326 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of NR4A2 mRNA CTD PMID:26577399 curcumin decreases expression ISO RGD:732028 6480464 Curcumin results in decreased expression of NR4A2 mRNA CTD PMID:17999991 cyclosporin A multiple interactions ISO RGD:736400 6480464 Cyclosporine inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A2 mRNA] CTD PMID:25451590 cyclosporin A decreases expression ISO RGD:732028 6480464 Cyclosporine results in decreased expression of NR4A2 mRNA CTD PMID:33631201 dabigatran multiple interactions EXP 6480464 Dabigatran inhibits the reaction [Rotenone results in decreased expression of NR4A2 mRNA] CTD PMID:28585189 DDE increases activity ISO RGD:732028 6480464 Dichlorodiphenyl Dichloroethylene results in increased activity of NR4A2 protein CTD PMID:27589886 decabromodiphenyl ether decreases expression EXP 6480464 decabromobiphenyl ether results in decreased expression of NR4A2 mRNA CTD PMID:23914054 deguelin decreases expression ISO RGD:732028 6480464 deguelin results in decreased expression of NR4A2 mRNA CTD PMID:33512557 dexamethasone increases expression ISO RGD:732028 6480464 Dexamethasone results in increased expression of NR4A2 mRNA CTD PMID:34742744 diarsenic trioxide decreases expression ISO RGD:732028 6480464 Arsenic Trioxide results in decreased expression of NR4A2 mRNA CTD PMID:26705709 dibutyl phthalate increases expression ISO RGD:736400 6480464 Dibutyl Phthalate results in increased expression of NR4A2 mRNA CTD PMID:21266533 dieldrin increases expression ISO RGD:732028 6480464 Dieldrin results in increased expression of NR4A2 mRNA CTD PMID:31068361 dieldrin affects methylation ISO RGD:736400 6480464 Dieldrin affects the methylation of NR4A2 gene CTD PMID:30859219 diheptyl phthalate decreases expression EXP 6480464 diheptyl phthalate results in decreased expression of NR4A2 mRNA CTD PMID:22112501 dipentyl phthalate decreases expression EXP 6480464 di-n-pentyl phthalate results in decreased expression of NR4A2 protein CTD PMID:36715143 disodium selenite increases expression ISO RGD:732028 6480464 Sodium Selenite results in increased expression of NR4A2 mRNA CTD PMID:18175754 dorsomorphin multiple interactions ISO RGD:732028 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A2 mRNA CTD PMID:27188386 doxorubicin decreases expression ISO RGD:732028 6480464 Doxorubicin results in decreased expression of NR4A2 mRNA CTD PMID:29803840 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of NR4A2 mRNA CTD PMID:32289291 Enterolactone multiple interactions ISO RGD:732028 6480464 [Coumestrol co-treated with 2, 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of NR4A2 mRNA CTD PMID:19167446 epoxiconazole increases expression ISO RGD:736400 6480464 epoxiconazole results in increased expression of NR4A2 mRNA CTD PMID:35436446 fenvalerate increases expression EXP 6480464 fenvalerate results in increased expression of NR4A2 mRNA CTD PMID:30307764 flavonoids decreases expression EXP 6480464 Flavonoids results in decreased expression of NR4A2 mRNA CTD PMID:18035473 fluoranthene multiple interactions ISO RGD:736400 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of NR4A2 mRNA CTD PMID:28329830 fluoxetine decreases expression ISO RGD:736400 6480464 Fluoxetine results in decreased expression of NR4A2 mRNA CTD PMID:20857517 flutamide increases expression EXP 6480464 Flutamide results in increased expression of NR4A2 mRNA CTD PMID:24793618 folic acid multiple interactions ISO RGD:736400 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NR4A2 gene CTD PMID:20938992 folic acid decreases expression ISO RGD:736400 6480464 Folic Acid results in decreased expression of NR4A2 mRNA CTD PMID:25629700 formaldehyde increases expression ISO RGD:732028 6480464 Formaldehyde results in increased expression of NR4A2 mRNA CTD PMID:17938736 , PMID:20655997 gamma-hexachlorocyclohexane increases expression EXP 6480464 Hexachlorocyclohexane results in increased expression of NR4A2 mRNA CTD PMID:8737662 geraniol increases expression ISO RGD:732028 6480464 geraniol results in increased expression of NR4A2 mRNA CTD PMID:27683099 glafenine multiple interactions ISO RGD:732028 6480464 Glafenine binds to and results in increased activity of NR4A2 protein CTD PMID:31175960 glutathione multiple interactions EXP 6480464 Glutathione inhibits the reaction [Permethrin results in increased expression of NR4A2 mRNA] CTD PMID:28943456 glycidol decreases expression EXP 6480464 glycidol results in decreased expression of NR4A2 mRNA CTD PMID:24915197 glycidol increases expression EXP 6480464 glycidol results in increased expression of NR4A2 mRNA CTD PMID:24395379 GW 1929 multiple interactions EXP 6480464 [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 mRNA, [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 protein CTD PMID:27435855 GW 1929 affects localization EXP 6480464 GW 1929 affects the localization of NR4A2 protein CTD PMID:27435855 heroin decreases expression EXP 6480464 Heroin results in decreased expression of NR4A2 mRNA CTD PMID:25643298 hydroquinone decreases expression ISO RGD:732028 6480464 hydroquinone results in decreased expression of NR4A2 mRNA CTD PMID:31256213 indometacin decreases expression ISO RGD:732028 6480464 Indomethacin results in decreased expression of NR4A2 mRNA CTD PMID:24737281 kainic acid increases expression EXP 6480464 Kainic Acid results in increased expression of NR4A2 mRNA CTD PMID:19700661 kainic acid increases expression ISO RGD:736400 6480464 Kainic Acid results in increased expression of NR4A2 protein CTD PMID:24813937 ketamine decreases expression EXP 6480464 Ketamine results in decreased expression of NR4A2 mRNA CTD PMID:20080153 L-gamma-glutamyl-L-cysteine multiple interactions ISO RGD:736400 6480464 gamma-glutamylcysteine promotes the reaction [amyloid beta-protein (1-42) results in increased expression of NR4A2 mRNA] more ... CTD PMID:35714925 L-methionine multiple interactions ISO RGD:736400 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in decreased methylation of NR4A2 gene CTD PMID:20938992 leptomycin B multiple interactions ISO RGD:736400 6480464 leptomycin B inhibits the reaction [sodium arsenite affects the localization of NR4A2 protein] CTD PMID:23283970 lipopolysaccharide multiple interactions ISO RGD:732028 6480464 [S-(1 more ... CTD PMID:35811015 lipopolysaccharide increases expression ISO RGD:732028 6480464 Lipopolysaccharides results in increased expression of NR4A2 mRNA CTD PMID:35811015 lithium atom increases expression ISO RGD:732028 6480464 Lithium results in increased expression of NR4A2 mRNA CTD PMID:21092101 lithium chloride multiple interactions EXP 6480464 CTNNB1 protein affects the reaction [Lithium Chloride results in increased expression of NR4A2 mRNA] more ... CTD PMID:27045591 lithium chloride increases expression EXP 6480464 Lithium Chloride results in increased expression of NR4A2 mRNA, Lithium Chloride results in increased expression of NR4A2 protein CTD PMID:27045591 lithium hydride increases expression ISO RGD:732028 6480464 Lithium results in increased expression of NR4A2 mRNA CTD PMID:21092101 lucanthone increases expression ISO RGD:732028 6480464 Lucanthone results in increased expression of NR4A2 mRNA CTD PMID:21148553 maneb multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of NR4A2 mRNA, [Paraquat co-treated with Maneb] results in decreased expression of NR4A2 protein CTD PMID:29152652 medroxyprogesterone acetate decreases expression ISO RGD:732028 6480464 Medroxyprogesterone Acetate results in decreased expression of NR4A2 mRNA CTD PMID:20843944 mercaptopurine increases expression EXP 6480464 Mercaptopurine results in increased expression of NR4A2 mRNA CTD PMID:27435855 mercaptopurine multiple interactions EXP 6480464 [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 mRNA more ... CTD PMID:27435855 metformin decreases expression EXP 6480464 Metformin results in decreased expression of NR4A2 mRNA CTD PMID:31324951 methamphetamine multiple interactions ISO RGD:736400 6480464 [SNCA protein co-treated with Methamphetamine] results in decreased expression of NR4A2 protein more ... CTD PMID:21151937 , PMID:32569805 methamphetamine decreases expression ISO RGD:736400 6480464 Methamphetamine results in decreased expression of NR4A2 protein CTD PMID:32569805 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of NR4A2 mRNA CTD PMID:19564919 methamphetamine multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of NR4A2 mRNA CTD PMID:19564919 methamphetamine affects response to substance ISO RGD:736400 6480464 NR4A2 protein affects the susceptibility to Methamphetamine CTD PMID:21151937 methimazole increases expression EXP 6480464 Methimazole results in increased expression of NR4A2 mRNA CTD PMID:22504374 methotrexate decreases expression ISO RGD:732028 6480464 Methotrexate results in decreased expression of NR4A2 CTD PMID:19732956 methylisothiazolinone increases expression ISO RGD:732028 6480464 2-methyl-4-isothiazolin-3-one results in increased expression of NR4A2 mRNA CTD PMID:31629900 methylmercury chloride affects expression ISO RGD:736400 6480464 methylmercuric chloride affects the expression of NR4A2 mRNA CTD PMID:21613230 methylmercury chloride increases expression ISO RGD:732028 6480464 methylmercuric chloride results in increased expression of NR4A2 mRNA CTD PMID:28001369 mitoxantrone affects response to substance ISO RGD:732028 6480464 NR4A2 protein affects the susceptibility to Mitoxantrone CTD PMID:16217747 mono(2-ethylhexyl) phthalate increases expression ISO RGD:732028 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of NR4A2 mRNA CTD PMID:19822197 monosodium L-glutamate multiple interactions ISO RGD:736400 6480464 [Trans Fatty Acids co-treated with Sodium Glutamate] results in increased expression of NR4A2 mRNA CTD PMID:22078008 morphine decreases expression EXP 6480464 Morphine results in decreased expression of NR4A2 mRNA CTD PMID:25643298 morphine multiple interactions EXP 6480464 Morphine inhibits the reaction [CREB1 protein modified form binds to NR4A2 promoter], Morphine inhibits the reaction [NR4A2 protein binds to BDNF promoter] CTD PMID:25643298 morphine affects response to substance ISO RGD:736400 6480464 NR4A2 protein affects the susceptibility to Morphine CTD PMID:25643298 morphine multiple interactions ISO RGD:736400 6480464 BDNF protein inhibits the reaction [NR4A2 protein affects the susceptibility to Morphine] CTD PMID:25643298 N(6)-butyryl-cAMP multiple interactions EXP 6480464 CREM protein inhibits the reaction [monobutyryl cyclic AMP results in increased expression of NR4A2 mRNA] CTD PMID:25381014 N(6)-butyryl-cAMP increases expression EXP 6480464 monobutyryl cyclic AMP results in increased expression of NR4A2 mRNA CTD PMID:25381014 N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide multiple interactions ISO RGD:732028 6480464 N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Dinoprostone co-treated with PTGER1 protein] results in increased expression of NR4A2 mRNA], N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide inhibits the reaction [[Dinoprostone co-treated with PTGER1 protein] results in increased expression of NR4A2 protein] CTD PMID:22188298 N-methyl-4-phenylpyridinium increases expression ISO RGD:736400 6480464 1-Methyl-4-phenylpyridinium results in increased expression of NR4A2 mRNA CTD PMID:26558463 naphthalenes increases expression EXP 6480464 Naphthalenes results in increased expression of NR4A2 protein CTD PMID:17337753 nickel atom increases expression ISO RGD:732028 6480464 Nickel results in increased expression of NR4A2 mRNA CTD PMID:23195993 nickel sulfate increases expression ISO RGD:732028 6480464 nickel sulfate results in increased expression of NR4A2 mRNA CTD PMID:16780908 nitrofen decreases expression EXP 6480464 nitrofen results in decreased expression of NR4A2 mRNA CTD PMID:33484710 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of NR4A2 mRNA CTD PMID:33387578 paraquat multiple interactions EXP 6480464 [Paraquat co-treated with Maneb] results in decreased expression of NR4A2 mRNA, [Paraquat co-treated with Maneb] results in decreased expression of NR4A2 protein CTD PMID:29152652 paraquat decreases expression ISO RGD:736400 6480464 Paraquat results in decreased expression of NR4A2 mRNA CTD PMID:21463325 paricalcitol multiple interactions ISO RGD:732028 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A2 mRNA CTD PMID:17715259 PCB138 multiple interactions ISO RGD:736400 6480464 [2 more ... CTD PMID:25510870 pentetrazol increases expression ISO RGD:736400 6480464 Pentylenetetrazole results in increased expression of NR4A2 mRNA CTD PMID:8164692 perfluorooctane-1-sulfonic acid affects expression ISO RGD:736400 6480464 perfluorooctane sulfonic acid affects the expression of NR4A2 mRNA CTD PMID:19429403 perfluorooctanoic acid affects expression ISO RGD:736400 6480464 perfluorooctanoic acid affects the expression of NR4A2 mRNA CTD PMID:19429403 permethrin decreases expression EXP 6480464 Permethrin results in decreased expression of NR4A2 more ... CTD PMID:22056222 more ... permethrin multiple interactions EXP 6480464 Glutathione inhibits the reaction [Permethrin results in increased expression of NR4A2 mRNA], Tocotrienols inhibits the reaction [Permethrin results in increased expression of NR4A2 mRNA] CTD PMID:28943456 permethrin affects binding ISO RGD:732028 6480464 Permethrin binds to [NR4A2 protein binds to NR4A2 protein] CTD PMID:31175960 permethrin affects expression EXP 6480464 Permethrin affects the expression of NR4A2 mRNA CTD PMID:23566817 permethrin increases expression EXP 6480464 Permethrin results in increased expression of NR4A2 mRNA, Permethrin results in increased expression of NR4A2 protein CTD PMID:23566817 more ... phencyclidine increases expression ISO RGD:736400 6480464 Phencyclidine results in increased expression of NR4A2 mRNA CTD PMID:17266109 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of NR4A2 mRNA CTD PMID:31324951 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:732028 6480464 [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A2 mRNA CTD PMID:16979875 phosphorus atom multiple interactions ISO RGD:732028 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A2 mRNA CTD PMID:17715259 phosphorus(.) multiple interactions ISO RGD:732028 6480464 [Phosphorus co-treated with paricalcitol] affects the expression of NR4A2 mRNA CTD PMID:17715259 picoxystrobin decreases expression ISO RGD:732028 6480464 picoxystrobin results in decreased expression of NR4A2 mRNA CTD PMID:33512557 pirimiphos-methyl increases activity ISO RGD:732028 6480464 pirimiphos methyl results in increased activity of NR4A2 protein CTD PMID:20143881 pirinixic acid multiple interactions ISO RGD:732028 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of NR4A2 mRNA CTD PMID:19710929 pirinixic acid increases expression ISO RGD:736400 6480464 pirinixic acid results in increased expression of NR4A2 mRNA CTD PMID:18301758 , PMID:20813756 potassium chloride increases expression EXP 6480464 Potassium Chloride results in increased expression of NR4A2 mRNA CTD PMID:8737662 potassium chromate multiple interactions ISO RGD:732028 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of NR4A2 mRNA CTD PMID:22079256 potassium chromate increases expression ISO RGD:732028 6480464 potassium chromate(VI) results in increased expression of NR4A2 mRNA CTD PMID:22079256 pregnenolone 16alpha-carbonitrile increases expression EXP 6480464 Pregnenolone Carbonitrile results in increased expression of NR4A2 mRNA CTD PMID:30047161 proanthocyanidin multiple interactions ISO RGD:732028 6480464 Proanthocyanidins inhibits the reaction [quinocetone metabolite results in decreased expression of NR4A2 mRNA] CTD PMID:26802905 probenecid multiple interactions ISO RGD:736400 6480464 1 more ... CTD PMID:25406165 propanal decreases expression ISO RGD:732028 6480464 propionaldehyde results in decreased expression of NR4A2 mRNA CTD PMID:26079696 prostaglandin E2 increases expression ISO RGD:736400 6480464 Dinoprostone results in increased expression of NR4A2 CTD PMID:16293616 prostaglandin E2 multiple interactions ISO RGD:732028 6480464 3-(4-methylphenylsulfonyl)-2-propenenitrile inhibits the reaction [[Dinoprostone co-treated with PTGER1 protein] results in increased expression of NR4A2 protein] more ... CTD PMID:22188298 purine-6-thiol increases expression EXP 6480464 Mercaptopurine results in increased expression of NR4A2 mRNA CTD PMID:27435855 purine-6-thiol multiple interactions EXP 6480464 [GW 1929 co-treated with Mercaptopurine] results in increased expression of NR4A2 mRNA more ... CTD PMID:27435855 rac-lactic acid increases expression ISO RGD:732028 6480464 Lactic Acid results in increased expression of NR4A2 mRNA CTD PMID:30851411 reactive oxygen species multiple interactions ISO RGD:732028 6480464 [[[CD40LG protein co-treated with IL4 protein] results in increased abundance of Reactive Oxygen Species] which results in increased expression of and results in increased phosphorylation of and results in increased stability of TP53 protein] which results in increased expression of NR4A2 mRNA CTD PMID:27634759 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of NR4A2 mRNA, Rotenone results in decreased expression of NR4A2 protein CTD PMID:19013527 more ... rotenone affects expression ISO RGD:732028 6480464 Rotenone affects the expression of NR4A2 mRNA CTD PMID:29428530 rotenone multiple interactions EXP 6480464 Dabigatran inhibits the reaction [Rotenone results in decreased expression of NR4A2 mRNA], Lithium Chloride inhibits the reaction [Rotenone results in decreased expression of NR4A2 protein] CTD PMID:27045591 , PMID:28585189 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:732028 6480464 [S-(1 more ... CTD PMID:35811015 SB 431542 multiple interactions ISO RGD:732028 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A2 mRNA CTD PMID:27188386 SCH 23390 multiple interactions EXP 6480464 [Methamphetamine co-treated with SCH 23390] results in increased expression of NR4A2 mRNA CTD PMID:19564919 SCH 23390 increases expression EXP 6480464 SCH 23390 results in increased expression of NR4A2 mRNA CTD PMID:19564919 serpentine asbestos increases expression ISO RGD:732028 6480464 Asbestos, Serpentine results in increased expression of NR4A2 mRNA CTD PMID:24160326 Shikonin multiple interactions ISO RGD:736400 6480464 shikonin inhibits the reaction [Antigen-Antibody Complex results in increased expression of NR4A2 mRNA], shikonin inhibits the reaction [Calcimycin results in increased expression of NR4A2 mRNA] CTD PMID:25451590 silicon dioxide decreases expression ISO RGD:732028 6480464 Silicon Dioxide analog results in decreased expression of NR4A2 mRNA CTD PMID:25895662 silicon dioxide decreases expression ISO RGD:736400 6480464 Silicon Dioxide results in decreased expression of NR4A2 mRNA CTD PMID:29203145 silicon dioxide increases expression ISO RGD:732028 6480464 Silicon Dioxide analog results in increased expression of NR4A2 mRNA CTD PMID:23806026 silicon dioxide increases expression ISO RGD:736400 6480464 Silicon Dioxide results in increased expression of NR4A2 mRNA CTD PMID:19073995 , PMID:33720480 silver atom affects expression ISO RGD:736400 6480464 Silver affects the expression of NR4A2 mRNA CTD PMID:27131904 silver(0) affects expression ISO RGD:736400 6480464 Silver affects the expression of NR4A2 mRNA CTD PMID:27131904 simazine increases expression ISO RGD:736400 6480464 Simazine results in increased expression of NR4A2 mRNA, Simazine results in increased expression of NR4A2 protein CTD PMID:32822773 simazine decreases expression ISO RGD:736400 6480464 Simazine results in decreased expression of NR4A2 mRNA, Simazine results in decreased expression of NR4A2 protein CTD PMID:34936186 simazine decreases expression EXP 6480464 Simazine results in decreased expression of NR4A2 mRNA, Simazine results in decreased expression of NR4A2 protein CTD PMID:29115391 simazine affects expression ISO RGD:736400 6480464 Simazine affects the expression of NR4A2 mRNA CTD PMID:27513680 simazine multiple interactions ISO RGD:736400 6480464 LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 mRNA], LMX1A protein promotes the reaction [Simazine results in increased expression of NR4A2 protein] CTD PMID:32822773 sodium arsenite multiple interactions ISO RGD:736400 6480464 [sodium arsenite affects the localization of NR4A2 protein] inhibits the reaction [NR4A2 protein results in increased expression of DDC mRNA] more ... CTD PMID:23283970 sodium arsenite decreases expression ISO RGD:732028 6480464 sodium arsenite results in decreased expression of NR4A2 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:736400 6480464 sodium arsenite results in decreased expression of NR4A2 mRNA CTD PMID:18812580 sodium arsenite affects localization ISO RGD:736400 6480464 sodium arsenite affects the localization of NR4A2 protein CTD PMID:23283970 sodium dichromate increases expression ISO RGD:736400 6480464 sodium bichromate results in increased expression of NR4A2 mRNA CTD PMID:27859739 sodium dodecyl sulfate increases expression ISO RGD:732028 6480464 Sodium Dodecyl Sulfate results in increased expression of NR4A2 mRNA CTD PMID:25377654 sodium fluoride decreases expression ISO RGD:736400 6480464 Sodium Fluoride results in decreased expression of NR4A2 mRNA CTD PMID:27862939 Soman increases expression EXP 6480464 Soman results in increased expression of NR4A2 mRNA CTD PMID:19281266 Soman decreases expression EXP 6480464 Soman results in decreased expression of NR4A2 mRNA CTD PMID:19281266 styrene decreases expression ISO RGD:736400 6480464 Styrene results in decreased expression of NR4A2 mRNA CTD PMID:28951217 sulfadimethoxine increases expression EXP 6480464 Sulfadimethoxine results in increased expression of NR4A2 mRNA CTD PMID:30047161 tamoxifen increases expression ISO RGD:736400 6480464 Tamoxifen results in increased expression of NR4A2 mRNA CTD PMID:25123088 temozolomide increases expression ISO RGD:732028 6480464 Temozolomide results in increased expression of NR4A2 mRNA CTD PMID:31758290 tetradecane increases expression EXP 6480464 n-tetradecane results in increased expression of NR4A2 protein CTD PMID:17337753 thalidomide increases expression ISO RGD:732028 6480464 Thalidomide analog results in increased expression of NR4A2 mRNA CTD PMID:20525221 thapsigargin increases expression ISO RGD:732028 6480464 Thapsigargin results in increased expression of NR4A2 mRNA CTD PMID:21694771 , PMID:29453283 thifluzamide decreases expression ISO RGD:732028 6480464 thifluzamide results in decreased expression of NR4A2 mRNA CTD PMID:33512557 thimerosal increases expression ISO RGD:732028 6480464 Thimerosal results in increased expression of NR4A2 mRNA CTD PMID:16870260 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of NR4A2 mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:736400 6480464 titanium dioxide results in increased expression of NR4A2 mRNA CTD PMID:23557971 titanium dioxide decreases expression ISO RGD:736400 6480464 titanium dioxide results in decreased expression of NR4A2 mRNA CTD PMID:29264374 topiramate decreases expression EXP 6480464 topiramate results in decreased expression of NR4A2 mRNA CTD PMID:16979414 torcetrapib increases expression ISO RGD:732028 6480464 torcetrapib results in increased expression of NR4A2 mRNA CTD PMID:19164467 more ... triacsin C decreases expression ISO RGD:732028 6480464 triacsin C results in decreased expression of NR4A2 mRNA CTD PMID:16704987 trichostatin A increases expression ISO RGD:732028 6480464 trichostatin A results in increased expression of NR4A2 mRNA CTD PMID:24935251 triphenylstannane decreases expression EXP 6480464 triphenyltin results in decreased expression of NR4A2 mRNA CTD PMID:32504733 triphenylstannane increases expression EXP 6480464 triphenyltin results in increased expression of NR4A2 mRNA, triphenyltin results in increased expression of NR4A2 protein CTD PMID:31765896 triptonide increases expression ISO RGD:736400 6480464 triptonide results in increased expression of NR4A2 mRNA CTD PMID:33045310 troglitazone decreases expression ISO RGD:736400 6480464 troglitazone results in decreased expression of NR4A2 mRNA CTD PMID:28973697 trovafloxacin increases expression ISO RGD:736400 6480464 trovafloxacin results in increased expression of NR4A2 mRNA CTD PMID:35537566 undecane increases expression EXP 6480464 undecane results in increased expression of NR4A2 protein CTD PMID:17337753 urethane decreases expression ISO RGD:732028 6480464 Urethane results in decreased expression of NR4A2 mRNA CTD PMID:28818685 valproic acid multiple interactions EXP 6480464 Valproic Acid promotes the reaction [NR4A2 protein binds to SLC6A3 promoter] CTD PMID:28743636 valproic acid multiple interactions ISO RGD:732028 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1, 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of NR4A2 mRNA CTD PMID:27188386 valproic acid decreases expression ISO RGD:732028 6480464 Valproic Acid results in decreased expression of NR4A2 mRNA CTD PMID:27188386 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of NR4A2 mRNA CTD PMID:28743636 valproic acid increases expression ISO RGD:732028 6480464 Valproic Acid results in increased expression of NR4A2 mRNA CTD PMID:23179753 more ... vinclozolin affects expression EXP 6480464 vinclozolin affects the expression of NR4A2 mRNA CTD PMID:19015723 vitamin D decreases expression EXP 6480464 Vitamin D deficiency results in decreased expression of NR4A2 mRNA, Vitamin D deficiency results in decreased expression of NR4A2 protein CTD PMID:28365874 zinc atom multiple interactions ISO RGD:732028 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A2 mRNA CTD PMID:16979875 , PMID:18593933 zinc(0) multiple interactions ISO RGD:732028 6480464 [PCI 5002 co-treated with Zinc] results in increased expression of NR4A2 mRNA, [Zinc co-treated with Tetradecanoylphorbol Acetate] affects the expression of NR4A2 mRNA CTD PMID:16979875 , PMID:18593933